High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group

被引:428
作者
Bhatia, S
Yasui, Y
Robison, LL
Birch, JM
Bogue, MK
Diller, L
DeLaat, C
Fossati-Bellani, F
Morgan, E
Oberlin, O
Reaman, G
Ruymann, FB
Tersak, J
Meadows, AT
机构
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Ist Nazl Tumori, I-20133 Milan, Italy
[6] Inst Gustave Roussy, Villejuif, France
[7] Columbus Childrens Hosp, Columbus, OH USA
[8] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[9] Childrens Mem Hosp, Chicago, IL 60614 USA
[10] Childrens Natl Med Ctr, Washington, DC 20010 USA
[11] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[12] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
D O I
10.1200/JCO.2003.11.059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We present an update of a previously reported Late Effects Study Group cohort of 1,380 children with Hodgkin's disease (HD) diagnosed between 1955 and 1986 in patients aged 16 years or younger. We describe the pattern and incidence of subsequent neoplasms (SNs) occurring with extended follow-up. Patients and Methods: Median age at diagnosis of HD was 11.7 years (range, 0.3 to 16.9 years) and at last follow-up was 27.8 years. Median length of follow-up was 17.0 years. Results: An additional 103 SNs were ascertained (total SNs = 212). The cohort was at an 18.5-fold increased risk of developing SNs compared with the general population (standardized incidence ratio [SIR], 18.5, 95% CI, 15.6 to 21.7). The cumulative incidence of any second malignancy was 10.6% at 20 years, increasing to 26.3% at 30 years; and of solid malignancies was 7.3% at 20 years, increasing to 23.5% at 30 years. Breast cancer was the most common solid malignancy (SIR, 56.7). Other commonly occurring solid malignancies included thyroid cancer (SIR, 36.4), bone tumors (SIR, 37.1), and colorectal (SIR, 36.4), lung (SIR, 27.3), and gastric cancers (SIR, 63.9). Risk factors for solid tumors included young age at HD and radiation-based therapy. Thirty-two patients developed third neoplasms, with the cumulative incidence approaching 21% at 10 years from diagnosis of second malignancy. Conclusion: Additional follow-up of this large cohort of HD survivors documents an increasing occurrence of known radiation-associated solid tumors, (breast and thyroid cancers), as well as emergence of epithelial neoplasms common in adults, (colon and lung cancers) at a younger age than expected in the general population, necessitating ongoing surveillance of this high risk population. (C) 2003 by American Society of Clinical Oncology.
引用
收藏
页码:4386 / 4394
页数:9
相关论文
共 53 条
  • [11] 2-6
  • [12] Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease
    Chung, CT
    Bogart, JA
    Adams, JF
    Sagerman, RH
    Numann, PJ
    Tassiopoulos, A
    Duggan, DB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02): : 405 - 409
  • [13] BREAST-CARCINOMA IN YOUNG-WOMEN PREVIOUSLY TREATED FOR HODGKIN DISEASE
    COOK, KL
    ADLER, DD
    LICHTER, AS
    IKEDA, DM
    HELVIE, MA
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (01) : 39 - 42
  • [14] Thyroid carcinomas after irradiation for a first cancer during childhood
    de Vathaire, F
    Hardiman, C
    Shamsaldin, A
    Campbell, S
    Grimaud, E
    Hawkins, M
    Raquin, M
    Oberlin, O
    Diallo, I
    Zucker, JM
    Panis, X
    Lagrange, JL
    Daly-Schveitzer, N
    Lemerle, J
    Chavaudra, J
    Schlumberger, M
    Bonaïti, C
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) : 2713 - 2719
  • [15] Brief report - Rectal cancer twenty-one years after treatment of childhood Hodgkin disease
    Deutsch, M
    Wollman, MR
    Ramanathan, R
    Rubin, J
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (04): : 280 - 281
  • [16] VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial
    Donaldson, SS
    Hudson, MM
    Lamborn, KR
    Link, MP
    Kun, L
    Billett, AL
    Marcus, KC
    Hurwitz, CA
    Young, JA
    Tarbell, NJ
    Weinstein, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3081 - 3087
  • [17] Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
    Dores, GM
    Metayer, C
    Curtis, RE
    Lynch, CF
    Clarke, EA
    Glimelius, B
    Storm, H
    Pukkala, E
    van Leeuwen, FE
    Holowaty, EJ
    Andersson, M
    Wiklund, T
    Joensuu, T
    van't Veer, MB
    Stovall, M
    Gospodarowicz, M
    Travis, LB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3484 - 3494
  • [18] Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO
  • [19] 2-F
  • [20] GROSS PE, 1998, J CLIN ONCOL, V16, P338